glp 1 2025 Q&A: Long-term success of GLP-1 therapies hinges on more than just a prescription New GLP-1 Guidelines for Type

The peptide is still absorbed

In 2024 alone, Canadian insurers paid nearly $77 million in claims for weight-management drugs, a figure that nearly doubled year over year [Source: endorhealth.com/article/generic-ozempic-coming-to-canada]

It remains the only medication specifically approved for reducing excess visceral abdominal fat in HIV-infected patients with lipodystrophy

Lee SJ, Wong M

Non-Arteritic anterior ischemic optic neuropathy (NA-AION): A comprehensive overview

Screening should also assess weight suppression (the difference between a patients maximum and current weight) and consider whether, following weight loss, patients experienced an intense fear of weight gain or symptoms of starvation (e.g., low body temperature, reduced heart rate, preoccupation with thoughts of food, irritability, decreased sexual desire, or social isolation)